文献速递其他结缔组织病

整合PET/CT表现与临床特征的新型简化综合评分系统用于风湿性多肌痛的开发

Development of a new simplified comprehensive scoring system for polymyalgia rheumatica: Integration of PET/CT findings and clinical features.
PubMed 文献 · Semin Arthritis Rheum · 2025-06-05

本研究基于既往单中心数据,将[18F]氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(PET/CT)表现与2012年ACR/EULAR风湿性多肌痛(PMR)分类标准整合,开发新型简化综合评分系统并在验证队列中评估诊断效能。研究回顾性纳入125例PMR患者和200例对照,发现队列中该系统诊断PMR的灵敏度为92%,在总体对照组中特异度为86.5%,区分类风湿关节炎(RA)的灵敏度为90.4%,总体对照组AUC为0.892,RA组AUC为0.912;验证队列中灵敏度为88%,特异度为83.1%。

要点

  • 新型简化综合评分系统整合PET/CT表现与2012年ACR/EULAR临床分类标准。
  • 发现队列中诊断PMR的灵敏度为92%,总体对照组特异度为86.5%。
  • 验证队列中灵敏度为88%,特异度为83.1%。

核心结论

  • 新型简化综合评分系统整合PET/CT表现与2012年ACR/EULAR临床分类标准,简化评分组分以提高诊断性能和临床实用性,使风湿科医生在临床环境中更易获取和使用。

研究设计与样本

  • 本研究基于既往单中心数据,对过去十年内接受PET/CT检查的年龄≥50岁肌肉骨骼疼痛患者进行回顾性综述,共纳入125例PMR患者和200例对照受试者,队列分为研究队列和验证队列,基于研究队列的PET/CT表现和临床特征开发新型简化综合评分系统,并在验证队列中进一步评估其诊断性能。

主要发现

  • 在发现队列中,整合PET/CT表现与临床标准的新评分系统诊断PMR的灵敏度为92%,在总体对照组中特异度为86.5%,区分类风湿关节炎(RA)患者的灵敏度为90.4%。
  • 在发现队列中,受试者工作特征曲线下面积(AUC)在总体对照组为0.892,在RA组为0.912。
  • 在验证队列中,新标准达到灵敏度88%和特异度83.1%。

关键数值与推荐

  • 新评分系统基于PET/CT表现与2012年ACR/EULAR分类标准整合,简化评分组分。
  • 发现队列:诊断PMR灵敏度92%,总体对照组特异度86.5%,区分RA灵敏度90.4%,总体对照组AUC 0.892,RA组AUC 0.912。
  • 验证队列:灵敏度88%,特异度83.1%。

临床怎么用

  • 作者认为,该新型简化综合评分系统简化了评分组分,提高了诊断性能和临床实用性,使风湿科医生在临床环境中更易获取和使用。

局限性

  • 本研究基于既往单中心数据。
  • 本研究为回顾性综述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study, based on previous single-center data, aimed to integrate [18F] Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) findings with the 2012 ACR/EULAR classification criteria for Polymyalgia rheumatica (PMR) to develop a new simplified comprehensive scoring system and further validate its diagnostic performance. METHODS: We conducted a retrospective review of patients aged ≥50 years with musculoskeletal pain who underwent PET/CT examinations over the past decade. A total of 125 patients with PMR and 200 control subjects were included. The cohort was divided into a study cohort and a validation cohort. Based on PET/CT findings and clinical characteristics from the study cohort, we developed a new simplified comprehensive scoring system. The diagnostic performance of this new scoring system was further assessed in the validation cohort. RESULTS: In the discovery cohort, the new scoring system, which combines PET/CT findings with clinical criteria, demonstrated a sensitivity of 92 % for diagnosing PMR, a specificity of 86.5 % in the overall control group, and a sensitivity of 90.4 % for distinguishing patients with rheumatoid arthritis (RA). The area under the receiver operating characteristic (ROC) curve (AUC) was 0.892 for the overall control group and 0.912 for the RA group. In the validation cohort, the new criteria achieved a sensitivity of 88 % and a specificity of 83.1 %. CONCLUSIONS: The new simplified comprehensive scoring system integrates PET/CT findings with the 2012 ACR/EULAR clinical classification criteria, simplifying the scoring components to improve diagnostic performance and clinical utility, thus making it more accessible and practical for rheumatologists in clinical settings.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Li Z, Chen K, Wu Y, et al. Development of a new simplified comprehensive scoring system for polymyalgia rheumatica: Integration of PET/CT findings and clinical features. Semin Arthritis Rheum. 2025. PMID: 40499500. doi:10.1016/j.semarthrit.2025.152767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。